ALK: Invitation to the presentation of ALKs first quarter 2025 results on Tuesday, 6 May 2025
ALK (ALKB.DC / OMX: ALK B) will publish its results for the first quarter of 2025 in the morning on Tuesday, 6 May 2025. Later on the same day, the company will host a presentation for investors and analysts at 11:00 a.m. CEST, where ALK's management will comment on the results and outlook and be [...]
Read full article »
ALK is a Denmark-based pharmaceutical company that researches and develops novel immunotherapies for the treatment of allergies and allergic asthma.
Read more